
CBAY
Franklin Resources’s Cymabay Therapeutics CBAY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-3,267,927
| Closed | -$77.2M | – | 2970 |
|
2023
Q4 | $77.2M | Sell |
3,267,927
-39,988
| -1% | -$945K | 0.04% | 392 |
|
2023
Q3 | $49.3M | Buy |
3,307,915
+35,907
| +1% | +$535K | 0.03% | 499 |
|
2023
Q2 | $35.8M | Buy |
3,272,008
+47,146
| +1% | +$516K | 0.02% | 623 |
|
2023
Q1 | $28.1M | Buy |
3,224,862
+3,201,765
| +13,862% | +$27.9M | 0.01% | 685 |
|
2022
Q4 | $145K | Hold |
23,097
| – | – | ﹤0.01% | 2064 |
|
2022
Q3 | $81K | Sell |
23,097
-1,367
| -6% | -$4.79K | ﹤0.01% | 2134 |
|
2022
Q2 | $72K | Sell |
24,464
-988
| -4% | -$2.91K | ﹤0.01% | 2196 |
|
2022
Q1 | $79K | Sell |
25,452
-5,381
| -17% | -$16.7K | ﹤0.01% | 2327 |
|
2021
Q4 | $104K | Sell |
30,833
-83,385
| -73% | -$281K | ﹤0.01% | 2335 |
|
2021
Q3 | $417K | Buy |
114,218
+92,215
| +419% | +$337K | ﹤0.01% | 1959 |
|
2021
Q2 | $96K | Hold |
22,003
| – | – | ﹤0.01% | 1914 |
|
2021
Q1 | $100K | Sell |
22,003
-207
| -0.9% | -$941 | ﹤0.01% | 1868 |
|
2020
Q4 | $127K | Sell |
22,210
-277
| -1% | -$1.58K | ﹤0.01% | 1775 |
|
2020
Q3 | $163K | Buy |
+22,487
| New | +$163K | ﹤0.01% | 1681 |
|
2020
Q2 | – | Sell |
-1,151,356
| Closed | -$1.7M | – | 1744 |
|
2020
Q1 | $1.7M | Hold |
1,151,356
| – | – | ﹤0.01% | 1120 |
|
2019
Q4 | $2.26M | Hold |
1,151,356
| – | – | ﹤0.01% | 1149 |
|
2019
Q3 | $5.9M | Hold |
1,151,356
| – | – | ﹤0.01% | 971 |
|
2019
Q2 | $8.24M | Buy |
1,151,356
+28,100
| +3% | +$201K | ﹤0.01% | 935 |
|
2019
Q1 | $14.9M | Sell |
1,123,256
-610,844
| -35% | -$8.11M | 0.01% | 799 |
|
2018
Q4 | $13.6M | Hold |
1,734,100
| – | – | 0.01% | 808 |
|
2018
Q3 | $19.2M | Sell |
1,734,100
-64,600
| -4% | -$716K | 0.01% | 796 |
|
2018
Q2 | $24.1M | Hold |
1,798,700
| – | – | 0.01% | 722 |
|
2018
Q1 | $23.4M | Buy |
1,798,700
+350,000
| +24% | +$4.55M | 0.01% | 739 |
|
2017
Q4 | $13.3M | Sell |
1,448,700
-51,300
| -3% | -$472K | 0.01% | 880 |
|
2017
Q3 | $12.1M | Buy |
+1,500,000
| New | +$12.1M | 0.01% | 906 |
|